GETAID is the main promoter of the SPARE clinical trial and is involved with French centres. GETAID is responsible for the global clinical study coordination.
The participating members are MJ. BERTIN, G. BRILLAULT and M. MANDRET.
UEDIN is the leader of the work on biomarkers and is involved in the SPARE clinical trial with UK centres.
The participating members are J. SATSANGI and H. ENNIS
RS-SUH has contributed to the design of the SPARE study protocol and is involved in the SPARE clinical trial with Swedish centres.
The participating members are E. HERTERVIG and S. ALMER.
The CHARITE is involved in the SPARE clinical trial with German centres.
The participating members are B. SIEGMUND and J. PREISS.
SRF is responsible for the pharmacokinetic and immunogenicity tests. SRF will participate in the interpretation of drug/anti-drug antibodies results for the outcome prediction.
The participating members are S. BEN-HORIN and O. PICARD.
IBDIM, the research organization affiliated to ECCO (European Crohn’s and colitis organization), is the continuous head of the dissemination process. IBDIM is responsible for managing the knowledge platform, the critical appraisal of the concept and organizing guidelines writing.
The participating members are J. GABRIEL, M. FERRANTE and C. LEES.
AFA is responsible for the patients’ perception survey.
The participating members are A. BUISSON and A. OLYMPIE.
UGOT is the leader of the work on health economics.
The participating member is K. BOLIN.
INSERM is in charge of the integration of both clinical and non-clinical data generated during the project in a comprehensive database. INSERM is also responsible for doing global analyses.
The participating members are S. CHEVRET, M. RESCHE-RIGON and J. LAMBERT.